Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging

NCT ID: NCT00401336

Last Updated: 2023-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor specificity and the most reliable method is histological or biochemical assessment from a liver biopsy. Because liver biopsy is an invasive procedure, imaging methods have been developed to detect and quantify hepatic iron content. The aim of the study is to use a simplified magnetic resonance imaging (MRI) technique to quantify simultaneously iron and fat contents in the liver and to compare the results to the quantification obtained biochemically.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor specificity and the most reliable method is histological or biochemical assessment from a liver biopsy. Because liver biopsy is an invasive procedure, imaging methods have been developed to detect and quantify hepatic iron content.

The aim of the study is to use a simplified magnetic resonance imaging technique to quantify simultaneously iron and fat contents in the liver and to compare the results to the quantification obtained biochemically.

Patients who need a liver biopsy will be proposed to be enrolled in the study. A magnetic resonance (MR) study will be performed using breath-hold gradient echo sequences with a single echo and a new multiple-echo gradient-echo sequence. Liver and muscle MR signal will be quantitatively determined and compared to biochemical assessment of liver iron concentration and steatosis quantification.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Overload Metabolic Syndrome X Hepatitis B Hepatitis C Alcohol Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Magnetic Resonance Imaging

New magnetic resonance imaging multiecho gradient-echo sequence

Group Type EXPERIMENTAL

Magnetic resonance imaging multiecho gradient-echo sequence

Intervention Type DEVICE

Breath-hold gradient echo sequences with a single echo and a new multiple-echo gradient-echo sequence

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic resonance imaging multiecho gradient-echo sequence

Breath-hold gradient echo sequences with a single echo and a new multiple-echo gradient-echo sequence

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults over 18,
* Planned liver biopsy (or liver biopsy within 2 months before inclusion) for one of these indications: suspicion of liver iron overload, metabolic syndrome, hepatitis B or C, alcohol abuse. No change in diet, transfusions or iron depletion must have occur between the liver biopsy and the MRI.
* Having given a written informed consent.

Exclusion Criteria

* Non cooperating patient,
* Patient with dyspnea,
* Patient with contra-indication to MR imaging (pace-maker, heart valve,...).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yves Gandon, MD

Role: STUDY_DIRECTOR

Rennes University Hospital

Eric Bellissant, MD, PhD

Role: STUDY_CHAIR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Angers

Angers, , France

Site Status

Hôpital Beaujon

Clichy, , France

Site Status

Hôpital Huriez

Lille, , France

Site Status

Hôpital Edouard Herriot

Lyon, , France

Site Status

Hôpital de la Timone

Marseille, , France

Site Status

Hôpital Saint Eloi

Montpellier, , France

Site Status

Hôpital Tenon

Paris, , France

Site Status

Hôpital de Pontchaillou

Rennes, , France

Site Status

Hôpital du Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Hopital Donostia-San Sebastian

Donostia / San Sebastian, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Spain

References

Explore related publications, articles, or registry entries linked to this study.

Paisant A, Boulic A, Bardou-Jacquet E, Bannier E, d'Assignies G, Laine F, Turlin B, Gandon Y. Assessment of liver iron overload by 3 T MRI. Abdom Radiol (NY). 2017 Jun;42(6):1713-1720. doi: 10.1007/s00261-017-1077-8.

Reference Type RESULT
PMID: 28224171 (View on PubMed)

Paisant A, Laine F, Gandon Y, Bardou-Jacquet E. Is room temperature susceptometer really an accurate method to assess hepatocellular iron? J Hepatol. 2017 Dec;67(6):1345-1346. doi: 10.1016/j.jhep.2017.07.021. Epub 2017 Aug 5. No abstract available.

Reference Type RESULT
PMID: 28789881 (View on PubMed)

d'Assignies G, Paisant A, Bardou-Jacquet E, Boulic A, Bannier E, Laine F, Ropert M, Morcet J, Saint-Jalmes H, Gandon Y. Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol. 2018 May;28(5):2022-2030. doi: 10.1007/s00330-017-5106-3. Epub 2017 Nov 24.

Reference Type RESULT
PMID: 29178028 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHRC/04-08

Identifier Type: -

Identifier Source: secondary_id

CIC0203/044

Identifier Type: -

Identifier Source: secondary_id

DGS 2006/0197

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CT Liver Fat Fraction Quantification
NCT05676177 ENROLLING_BY_INVITATION NA
MRI in Portal Hypertension
NCT01756859 UNKNOWN
MRI to Measure Liver Fat Content
NCT00594412 COMPLETED NA